BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Charles Hsu will be a keynote speaker at the annual meeting of the Sino-American Pharmaceutical Association (West) in San Francisco
News | 04. 15. 2006
